Pulpotomy in primary teeth

Phase 3

Not yet recruiting

• Conditions: normal healthy person with deep dental carious lesion

• Registration Number: CTRI/2018/06/014414
• Lead Sponsor: not applicable

Brief Summary

This aim of this study to evaluate clinical and radiographic success of pulpotomy by using MTA, Er, Cr: YSGG LASER and Biodentin in primary teeth. There are various materials used for the pulpotomy. MTA, Er.Cr;YSGG laser, Biodentine  laser are the recent  materials can be used for the pulpotomy.MTA has demonstrated the ability to induce hard-tissue formation in pulpal tissues, and it promotes rapid cell growth in vivo. Compared with calcium hydroxide, MTA has demonstrated a greater ability to maintain the integrity of pulp tissue.The clinical and radiological success rate of Biodentine for pulpotomy are extensively being studied. Biodentine has success rates similar to that of mineral trioxide aggregate (MTA) i.e. 94.7% with additional benefits of faster setting time and better odontoblastic activity.The effects of Er.Cr;YSGG laser irradiation on the pulp tissue during a pulpotomy procedure were evaluated histopathologically. Effects on pulp tissues during a pulpotomy procedure by Er.Cr;YSGG laser irradiation are minimal, if appropriate parameters are selected, and this is a potential therapy for pulpotomy of human teeth.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2018-05-06
• Study Start: 2018-07-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

• Deep carious lesion in primary molars.
• No history of spontaneous pain.
• No clinical and radiographic evidence of inflamed pulp and degeneration such as uncontrolled bleeding.
• No swelling or sinus tract.
• No inter radicular or periapical bone destruction.
• Positive parental informed consent.
• No underlying systemic or metabolic disorders who may lead to loss of follow up visits.

Exclusion Criteria

• Excessive bleeding from pulp chamber.
• Any sign of pulpal degeneration.
• History of spontaneous pain.
• Inter radicular or periapical bone destruction as seen on radiographs.
• Children with special health care needs who may not be able to visit or follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
2. No clinical and radiographic evidence of inflamed pulp and degeneration such as uncontrolled bleeding.	6 months
3. No swelling or sinus tract.	6 months
1. No history of spontaneous pain.	6 months

Secondary Outcome Measures

Name	Time	Method
no interradicular bone destruction	6 months

Trial Locations

Locations (1)

maulana azad institute of dental sciences; 🇮🇳 Delhi, DELHI, India

maulana azad institute of dental sciences

🇮🇳Delhi, DELHI, India

Dr RAMANANDVIGNESH

Principal investigator

9870144893

ramanand.vignesh92@gmail.com